Jun 01, 2020 / 02:00PM GMT
Ben Matone - Inovio Pharmaceuticals, Inc. - Director of IR
Good morning. My name is Ben Matone, and I'm Senior Director of Investor Relations at Inovio. We're excited to have you join us for the first ever Inovio webinar entitled DNA Medicines from COVID-19 to Cancer.
Before we begin, I'd like to remind everyone that we will be making certain forward-looking statements regarding future events that relate to our business plans to develop Inovio's integrated platform of DNA Medicines. These include clinical and regulatory developments and timing of clinical data readouts and strategic matters. All of these statements are based on the beliefs and expectations of management as of today. These statements involve certain assumptions, risk and uncertainties and could cause actual results to differ materially. We assume no obligation to revise or update forward-looking statements, whether as a result of new information, future events or otherwise.
Thank you again for being with us today. And with that, I would like to turn the presentation over to Dr. Joseph Kim, President and CEO of Inovio.
Inovio Pharmaceuticals, Inc. - Special Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers